Rejection Prophylaxis

Rejection Prophylaxis is a transplant pharmacotherapy strategy that employs planned immunosuppressive regimens initiated before or immediately after organ or tissue transplantation to prevent, rather than treat, immune-mediated graft rejection.

518

Publications

27.5K

Citations

3.6K

Authors

788

Institutions

Publications per year

2017–2026

69

Publications

518

1–5 of 518

Authors

3.6K

  1. RS
    Rainer Storb

    Fred Hutch Cancer Center, United States

    12 publications · 1.9K citations

    12

    h-index

  2. JH
    Joseph H. Antin

    Dana-Farber Cancer Institute, United States

    10 publications · 2.3K citations

    10

    h-index

  3. CA
    Claudio Anasetti

    Fred Hutch Cancer Center, United States

    9 publications · 1K citations

    9

    h-index

  4. PJ
    Paul J. Martin

    Fred Hutch Cancer Center, United States

    9 publications · 754 citations

    9

    h-index

  5. FV
    Flavio Vincenti

    University of California, San Francisco, United States

    8 publications · 754 citations

    8

    h-index

1–5 of 3.6K

Venues

  1. Transplantation

    55 publications · 3.4K citations

    35

    h-index

  2. PubMed

    Repository · 92 publications · 4.1K citations

    33

    h-index

  3. Blood

    29 publications · 3.8K citations

    23

    h-index

  4. Transplantation Proceedings

    49 publications · 1K citations

    21

    h-index

  5. American Journal of Transplantation

    22 publications · 2.6K citations

    19

    h-index

1–5